Market Tracker

08/21 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.70
Data as of 4:00pm ET
 -0.0089 / -1.26%
Today’s Change
0.36
Today|||52-Week Range
1.85
+37.25%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.71
Today’s open0.72
Day’s range0.69 - 0.72
Volume363,815
Average volume (3 months)1,179,324
Market cap$126.4M
Dividend yield--
Data as of 4:00pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-71.43%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.24

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...+0.19+1.98%
NERVMinerva Neuroscience...+0.08+1.20%
RDHLRedhill Biopharma Lt...+0.01+0.08%
MDGNMedgenics Inc-0.14-2.17%
Data as of 3:59pm ET, 08/21/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts